Skip to main content

Year: 2025

La-Z-Boy Incorporated Announces Timing of Fiscal 2026 Second Quarter Earnings Release and Conference Call

MONROE, Mich., Nov. 04, 2025 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB) will report its Fiscal 2026 Second Quarter results for the period ended October 25, 2025 after the close of trading on the New York Stock Exchange on Tuesday, November 18, 2025, and will hold its quarterly investor conference call at 8:30 a.m. Eastern Time the following day, Wednesday, November 19, 2025. The conference call will be webcast live with corresponding slides at https://lazboy.gcs-web.com/. The dial-in phone number for the live conference call will be (888) 506-0062 for persons calling from within the U.S. or Canada, and the number for international callers will be (973) 528-0011. The participant access code is 973736. The conference call will be archived on the internet and accessible for one year. A telephone replay will be available...

Continue reading

Leviathan Gold Announces Receipt of Conditional Approval of the TSXV to Acquire Cura Exploration Botswana Corp. and its 100% Interest in Kalahari Copper and Uranium Exploration Portfolios, Botswana

VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) — Leviathan Gold Ltd. (“Leviathan” or the “Company”) (LVX – TSXV, LVXFF – OTC, 0GP – FSE) is pleased to announce that it has received conditional approval of the TSX Venture Exchange (the “TSXV”) with respect to the previously announced proposed acquisition (the “Transaction”) of all of the issued and outstanding securities of Cura Exploration Botswana Corp. (“Cura”), further to its previous announcements on June 19, 2025, July 16, 2025, August 18, 2025, September 11, 2025 and October 20, 2025. Additionally, the Company announces that it has entered into an amending agreement dated October 31, 2025 (the “Amending Agreement”) to amend the terms of the amalgamation agreement dated September 11, 2025 (the “Amalgamation Agreement”) between the Company, Cura and 1555801 B.C....

Continue reading

Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights

—  Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7%  — Third quarter pulse recurring revenue of $8.3M, +55% year-over-year growth — First nine months revenue of $58.7M, +42% year-over-year growth; IFRS gross margin of 75.1% — First nine months IFRS and non-IFRS net income of $1.4M and $3.2M, respectively, versus a net loss of $3.8M and $2.1M, respectively, in the same year ago period — Approximately 667,00 pulse treatments administered since commercialization — Company expects to achieve net profitability in 2025 SAN CLEMENTE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the third quarter and first nine...

Continue reading

Orbit International’s Simulator Product Solutions Reports Bookings in Excess of $1,000,000 for Month of October 2025

HAUPPAUGE, N.Y., Nov. 04, 2025 (GLOBE NEWSWIRE) — Orbit International Corp. (the “Company”) (OTCID Basic Market:ORBT), an electronics manufacturer and software solution provider, today announced that its Simulator Product Solutions LLC (“SPS”) subsidiary recorded bookings in excess of $1,000,000 for the month of October 2025. Deliveries for orders received during the month are expected to commence in the fourth quarter of 2025 and are expected to continue through the third quarter of 2026. Mitchell Binder, President and CEO of Orbit International commented, “We are pleased to report firm bookings in excess of $1,000,000 for SPS for the month of October 2025. This month of firm bookings was mostly attributable to a significant order received for a simulator used by the U.S. National Guard. The award had been expected for some time...

Continue reading

Wisconsin University Selects OMNIQ’s AI Access-Control Technology to Strengthen Campus Safety and Efficiency

SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) — OMNIQ CORP. (OTCMKTS: OMQS) (“OMNIQ” or “the Company”), a leader in AI-based computer vision and data intelligence, is chosen by a public research university in Wisconsin to implement advanced access-control technology across campus facilities and parking areas. The project aims to support safer, more efficient daily operations through automated credentialing, role-based permissions, and centralized management. Serving approximately 50,000 students and 27,000 faculty and staff, the university joins a growing number of higher-education institutions adopting OMNIQ systems to enhance visibility and control in complex environments. This automation reduces waiting times, limits the need for on-site attendants, and eliminates the costs and errors associated with printed credentials. By...

Continue reading

SFL – Invitation to Presentation of Q3 2025 Results

SFL Corporation Ltd. (“SFL” or the “Company”) (NYSE: SFL) plans to release its preliminary financial results for the third quarter of 2025 on Tuesday, November 11, 2025. SFL plans to host a conference call and webcast for all stakeholders and interested parties on Tuesday, November 11, 2025, at 10:00 AM (EST) / 4:00 PM (CET). Relevant material will on the same day be available from the Investor Relations section of the Company’s website at www.sflcorp.com. In order to listen to the conference call and presentation, you may do one of the following:  A: Join Conference Call Webcast in Listen Only Mode:Visit the Investor Relations section of the Company’s website at www.sflcorp.com and click on the link to “Webcast”, or access directly via the webcast link below. The webcast with slideshow will be played live from...

Continue reading

KVH Industries to Host Third Quarter Conference Call on November 6, 2025

MIDDLETOWN, R.I., Nov. 04, 2025 (GLOBE NEWSWIRE) — KVH Industries, Inc. (Nasdaq: KVHI), will announce its financial results for the third quarter that ended on September 30, 2025, on Thursday, November 6, 2025. In conjunction with the release, the company will conduct its investor conference call at 9:00 a.m. ET, hosted by Mr. Brent Bruun, CEO, and Mr. Anthony Pike, CFO. A live broadcast of the call will be available online at investors.kvh.com. In addition, an audio replay of the conference call will be available on the website for at least two weeks. To listen to the replay, visit investors.kvh.com starting three hours following the conclusion of the call. Investors who wish to submit questions during or following the call may do so to IR@kvh.com. About KVH Industries, Inc. KVH Industries, Inc. is a global leader in maritime...

Continue reading

Telesat invests US$5 million in Farcast to develop fully integrated User Terminals for Telesat Lightspeed satellite network

OTTAWA and SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) — Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, today announced an expanded relationship with Farcast, a San Francisco-based startup that is building advanced satellite User Terminals. Under the new agreement, Farcast will deliver an enterprise-class Flat Panel Antenna (FPA) User Terminal that is fully integrated with the Telesat Lightspeed modem and ready for volume production. Additionally, Telesat is making a US$5 million equity investment in Farcast and will take a seat on Farcast’s board of directors to support the company’s alignment with the goals of the Telesat Lightspeed program. Farcast has developed a unique technology that can simultaneously transmit and receive data from the same aperture in an FPA. This proprietary...

Continue reading

BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections

New FDA feedback confirms clinical pathway for fixed multi-phage cocktail BX011, expanding development into diabetic foot infections (DFI) and unlocking a major commercial opportunity NESS ZIONA, Israel, Nov. 04, 2025 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that it has received positive feedback from the U.S. Food and Drug Administration (FDA) on the proposed clinical developmental pathway for BX011, a next-generation fixed multi-phage cocktail targeting Staphylococcus aureus (S. aureus) in diabetic foot infections (DFI). FDA feedback supports BiomX’s plan to advance its phage-based therapy into DFI as the next clinical indication, following the Company’s...

Continue reading

Tarkett – Information on the total number of voting rights and shares in Tarkett’s share capital as of October, 31st, 2025

 PARIS, FRANCE, 4th of November 2025 – Information on the total number of voting rights and shares in Tarkett’s share capital as of October 31st, 2025 (Article L233-8-II of the French Commercial Code andArticle 223-16 of the General Regulation of the Autorité des marchés financiers)Date Total number of shares in the share capital Total number of voting rightsAs of October 31st, 2025   65,550,281   Number of theoretical voting rights: 123 938 579  Number of exercisable voting rights: 123 920 020** After deduction of the treasury shares without voting rights. *** Investor Relations Contact investors@tarkett.com Media ContactTarkett – communication@tarkett.comOgilvy – emmeline.jacob@ogilvy.com – +33 6 79 39 75 04Ogilvy – marceau.barbedette@ogilvy.com – + 33 6 01 16 08 94 About Tarkett With a history...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.